Localized pmrB hypermutation drives the evolution of colistin heteroresistance

Cell Rep. 2022 Jun 7;39(10):110929. doi: 10.1016/j.celrep.2022.110929.

Abstract

Colistin has emerged as an important last line of defense for the treatment of infections caused by antibiotic-resistant gram-negative pathogens, but colistin resistance remains poorly understood. Here, we investigate the responses of ≈1,000 populations of a multi-drug-resistant (MDR) strain of P. aeruginosa to a high dose of colistin. Colistin exposure causes rapid cell death, but some populations eventually recover due to the growth of sub-populations of heteroresistant cells. Heteroresistance is unstable, and resistance is rapidly lost under culture in colistin-free medium. The evolution of heteroresistance is primarily driven by selection for heteroresistance at two hotspot sites in the PmrAB regulatory system. Localized hypermutation of pmrB generates colistin resistance at 103-104 times the background resistance mutation rate (≈2 × 10-5 per cell division). PmrAB provides resistance to antimicrobial peptides that are involved in host immunity, suggesting that this pathogen may have evolved a highly mutable pmrB as an adaptation to host immunity.

Keywords: AMR; CP: Microbiology; Pseudomonas aeruginosa; antibiotic resistance; colistin; evolutionary rescue; experimental evolution; heteroresistance; hypermutability; mutation rate.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Bacterial Proteins* / genetics
  • Bacterial Proteins* / metabolism
  • Colistin* / pharmacology
  • Drug Resistance, Bacterial / genetics
  • Microbial Sensitivity Tests
  • Pseudomonas aeruginosa / genetics
  • Pseudomonas aeruginosa / metabolism

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Colistin